Biodesix Inc. (BDSX) Reports In-Line Q1 EPS

Biodesix Inc. (NASDAQ: BDSX) reported Q1 EPS of ($0.24), in-line with the analyst estimate of ($0.24). Revenue for the quarter came in at $9.05 million versus the consensus estimate of $11.39 million.

For earnings history and earnings-related data on Biodesix Inc. (BDSX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
• Movano (MOVE) Misses Q2 EPS by 195c